Abstract
IntroductionA growing number of patients are at risk from chronic anthracycline cardiotoxicity (cAC) as a result of improving prognosis of cancer. This is true even at low, adjuvant doses. In...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
